Os extratos etanólicos das folhas e raízes de Combretum leprosum Mart. & Eicher (Combretaceae) foram investigados por CGAR-EM, após derivatização com BSTFA/ TMCS. Mono e oligossacarídeos, ácidos graxos e triterpenos foram identificados como componentes majoritários. Análise quantitativa por padronização externa revelou a presença de 65% de ácido arjunólico (1) no extrato etanólico das raízes secas. Foram observadas atividades anti-inflamatória, antinociceptiva e anticolinesterásicas (AChE e BuChE) para o extrato das raízes e para o ácido arjunólico, descortinando uma nova classe de produtos naturais no tratamento da doença de Alzheimer através de drogas multifuncionais.
Introduction
Combretum leprosum Mart. & Eicher (Combretaceae), native from Brazil, is a widely distributed shrub in Brazilian Caatinga from Piauí to Bahia states and is commonly known as "mofumbo". 1 It is used by local people on the cicatrisation of wounds, in the treatment of haemorrhages or as a sedative, 2 and the analgesic property of the ethanolic stem barks extract was recently described. 3 Braz-Filho et al. 4 studied two genera of Combretaceae.
From Thiloa glaucocarpa they isolated arjunolic acid (1) and from Combretum sp., 3,3',4,5-tetra-Omethylflavellagic acid, ethyl β-D-glucopyranoside and arjunglucoside. 4 C. leprosum roots and leaves led to the isolation of arjunolic and mollic acids, 3β,6β,16βtrihydroxylup-20(29)-ene (2), together with the glycosilated flavonoids 3-O-methylquercetin and quercetrin. 5 Arjunolic acid (2α, 3β, 23-trihydroxyolean-12-en-28oic acid, 1) was first isolated from Terminalia arjuna (Combretaceae), which has been used as a cardiac tonic by native Ayurvedic Indian people for centuries. 6 A patent J. Braz. Chem. Soc. based on the hormonal, wound healing and bactericide (particularly Mycobacterium tuberculosis and M. leprae) properties of arjunolic acid and its isomer, asiatic acid (2α, 3β, 23-trihydroxyursan-12-en-28-oic acid, 3) was deposited 7 and, since then, a series of other biological activities of arjunolic acid were described. 8 Continuing our search for anti-inflammatory and anticholinesterasic agents from natural sources, 9 we found Combretum leprosum as an interesting investigation target. It merged from the relatively few reported information about pharmacological profile of C. leprosum and the structural similarity of arjunolic and asiatic acids.
Analysis of the leaf ethanolic extract of C. leprosum by HRGC-MS, 10,11 after derivatization with BSTFA/TMCS (1%) in pyridine, 12 led to the identification of monosaccharides as major compounds (80%), followed by minor oligosaccharides (5%), fatty acids (3%) and triterpenes (10%). The known pentacyclic triterpenes 3β,6β,16βtrihydroxylup-20(29)-ene (2) and arjunolic acid (1) were also derivatized and co-injected with the leaf extract, confirming their presence in very low amounts ( Figure 1 ).
HRGC-MS of roots ethanolic extract of C. leprosum derivatized with BSTA/TMS revealed a high amount of arjunolic acid (1) besides minor triterpene (Figure 2 , D), all them with two characteristic fragments at m/z 203 and 320 due to a retro Diels-Alder rearrangement at C-ring double bond. 13 Carbohydrates, mainly represented by monosaccharides (confirmed by co-injection of derivatized glucose and fructose) and fatty acids (oleic, linoleic and linolenic acids), were also observed. Co-injection with derivatized arjunolic acid and external standard calibration revealed the presence of 1 in 65% on the ethanolic extract obtained from dried roots.
Three sets of assays were used to investigate the antiinflammatory activity of roots and leaves extracts and of pure arjunolic acid (1). 14 Unlike leaves, roots extract (200 mg kg -1 ) and arjunolic acid (100 mg kg -1 ) were able to inhibit significantly the carrageenan-induced paw edema with 37.6% and 80.8% of inhibition, respectively. At this dose, arjunolic acid was very gastrotoxic inducing a hemorrhagic damage of the gastric mucosa. 15 Meanwhile, at a lower dose of 10 mg kg -1 , toxicity was not observed and arjunolic acid (1) stayed inhibiting significantly the edema by 37.6%. Root extract (200 mg kg -1 ) and arjunolic acid (10 mg kg -1 ) inhibited the acetic acid-induced constrictions by 33% and 30.3% respectively. 14 The arachidonic acid (AA) and 12-O-tetradecanophorbol-13-acetate (TPA) induced ear edemas are widely used to evaluate the anti-inflammatory activity of cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors. Arjunolic acid showed a similar profile of indomethacin, inhibiting the AA-induced ear edema by 55.5% without interfere with the TPA-induced one. 16 Taken together, the overall results suggested that arjunolic acid affect the AA metabolism by cyclooxygenase, thus exerting its antiinflammatory and antinociceptive activities.
Similar to anti-inflammatory results, only the root extract inhibited acetyl and butyril cholinesterase enzymes. Using the modified Ellman's method in TLC, 17 arjunolic acid proved to be the responsible for these activities. The acid 1 inhibited both cholinesterases at the same reference compound concentration limit (physostigmine, 0.01 mmol L -1 ). No cholinesterase activity was observed for 3β,6β,16β-trihydroxylup-20(29)-ene (2) and nor to 3β-hydroxylup-20(29)-ene (lupeol). Associated to the negative cholinesterase activity observed for oleanolic acid (3β-hydroxyolean-12-en-28-oic acid), 18 these results suggest an important biological role in C(2)-and C(23)-OH groups added to topological differences on these triterpenes. Studies on the neuroprotective action of asiatic acid (2α, 3β, 23trihydroxyursan-12-en-28-oic acid, 3) and derivatives showed that free C(28)-CO 2 H and the triol groups are very important against (Aβ)-induced neurotoxicity. 19 (1) and 3β,6β,16β-trihydroxylup-20(29)-ene (2) . Arjunolic Acid in the Ethanolic Extract of Combretum leprosum Root Vol. 16, No. 6B, 2005 The small structural difference between arjunolic (1) and asiatic (3) acids, together with literature data on the oxidative stress reduction property of both acids 20 and our antiinflammatory and anticholinesterasic results of arjunolic acid, suggest these compounds as promising models for the development of innovative multi-functional drugs for AD treatment. 21 As "Mofumbo" root major compound is arjunolic acid, followed by small amounts of monosaccharide and fatty acids, it can be a powerful candidate for the development of a new phytomedicine for neurodegenerative disorders.
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